Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Details of updates to PTSC Business Overview Presentation

Thanks StormKing...good info on the comparisons....they sure dropped that word "annuity" quickly...and for whatever reason are downplaying the MMP revenues to date and future revenues from licensing to show...IMO at least...that they are expecting (as their pie chart had shown) a 1/3 to 2/3 split on licensing to ongoing revenue...more stress that ongoing revenue base will be funded by the licensing revenue.

Share
New Message
Please login to post a reply